Multimorbidity and the Etiology of Schizophrenia
Curr Psychiatry Rep. 2024 Apr 16. doi: 10.1007/s11920-024-01500-9. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: A global study of multimorbidity in schizophrenia, especially of the association with physical conditions, might offer much needed etiological insights.RECENT FINDINGS: Our review suggests that life-style factors and medication related to schizophrenia are only part of the explanation of the increase in risk for cardiovascular, metabolic, pulmonary disorders, and some cancers. Positive associations with autoimmune disorders (with the exception of rheumatoid arthritis) and epilepsy are promising avenues of res...
Source: Epilepsy Curr - April 16, 2024 Category: Neurology Authors: A Szoke B Pignon O Godin A Ferchiou R Tamouza M Leboyer F Sch ürhoff Source Type: research
Multimorbidity and the Etiology of Schizophrenia
Curr Psychiatry Rep. 2024 Apr 16. doi: 10.1007/s11920-024-01500-9. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: A global study of multimorbidity in schizophrenia, especially of the association with physical conditions, might offer much needed etiological insights.RECENT FINDINGS: Our review suggests that life-style factors and medication related to schizophrenia are only part of the explanation of the increase in risk for cardiovascular, metabolic, pulmonary disorders, and some cancers. Positive associations with autoimmune disorders (with the exception of rheumatoid arthritis) and epilepsy are promising avenues of res...
Source: Epilepsy Curr - April 16, 2024 Category: Neurology Authors: A Szoke B Pignon O Godin A Ferchiou R Tamouza M Leboyer F Sch ürhoff Source Type: research
Revolutionizing Neurological Disorder Treatment: Integrating Innovations in Pharmaceutical Interventions and Advanced Therapeutic Technologies
Curr Pharm Des. 2024 Apr 9. doi: 10.2174/0113816128284824240328071911. Online ahead of print.ABSTRACTNeurological disorders impose a significant burden on individuals, leading to disabilities and a reduced quality of life. However, recent years have witnessed remarkable advancements in pharmaceutical interventions aimed at treating these disorders. This review article aims to provide an overview of the latest innovations and breakthroughs in neurological disorder treatment, with a specific focus on key therapeutic areas such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke. This review ...
Source: Epilepsy Curr - April 15, 2024 Category: Neurology Authors: Rimpi Arora Ashish Baldi Source Type: research
Decrease in phase slip rates and phase cone structures during seizure evolution and epileptogenic activities derived from microgrid ECoG data
Curr Res Neurobiol. 2024 Feb 19;6:100126. doi: 10.1016/j.crneur.2024.100126. eCollection 2024.ABSTRACTSudden phase changes are related to cortical phase transitions, which likely change in frequency and spatial distribution as epileptogenic activity evolves. A 100 s long section of micro-ECoG data obtained before and during a seizure was selected and analyzed. In addition, nine other short-duration epileptic events were also examined. The data was collected at 420 Hz, imported into MATLAB, downsampled to 200 Hz, and filtered in the 1-50 Hz band. The Hilbert transform was applied to compute the analytic phase, which was the...
Source: Epilepsy Curr - April 15, 2024 Category: Neurology Authors: Ceon Ramon Alexander Doud Mark D Holmes Source Type: research
Revolutionizing Neurological Disorder Treatment: Integrating Innovations in Pharmaceutical Interventions and Advanced Therapeutic Technologies
Curr Pharm Des. 2024 Apr 9. doi: 10.2174/0113816128284824240328071911. Online ahead of print.ABSTRACTNeurological disorders impose a significant burden on individuals, leading to disabilities and a reduced quality of life. However, recent years have witnessed remarkable advancements in pharmaceutical interventions aimed at treating these disorders. This review article aims to provide an overview of the latest innovations and breakthroughs in neurological disorder treatment, with a specific focus on key therapeutic areas such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke. This review ...
Source: Epilepsy Curr - April 15, 2024 Category: Neurology Authors: Rimpi Arora Ashish Baldi Source Type: research
Decrease in phase slip rates and phase cone structures during seizure evolution and epileptogenic activities derived from microgrid ECoG data
Curr Res Neurobiol. 2024 Feb 19;6:100126. doi: 10.1016/j.crneur.2024.100126. eCollection 2024.ABSTRACTSudden phase changes are related to cortical phase transitions, which likely change in frequency and spatial distribution as epileptogenic activity evolves. A 100 s long section of micro-ECoG data obtained before and during a seizure was selected and analyzed. In addition, nine other short-duration epileptic events were also examined. The data was collected at 420 Hz, imported into MATLAB, downsampled to 200 Hz, and filtered in the 1-50 Hz band. The Hilbert transform was applied to compute the analytic phase, which was the...
Source: Epilepsy Curr - April 15, 2024 Category: Neurology Authors: Ceon Ramon Alexander Doud Mark D Holmes Source Type: research
Levetiracetam Induced Behavioural Changes in an Adult Female Patient: A Case Report
CONCLUSION: Consequently, the drug was discontinued, resulting in the resolution of the behavioural symptoms. This case highlights levetiracetam as the likely causative factor behind the observed significant behavioural changes.PMID:38584560 | DOI:10.2174/0115748863285429240326172920 (Source: Epilepsy Curr)
Source: Epilepsy Curr - April 8, 2024 Category: Neurology Authors: Hemangi Amrutbhai Virani Hetal Kantilal Dabhi Piyushkumar Mansinh Pargi Source Type: research
Levetiracetam Induced Behavioural Changes in an Adult Female Patient: A Case Report
CONCLUSION: Consequently, the drug was discontinued, resulting in the resolution of the behavioural symptoms. This case highlights levetiracetam as the likely causative factor behind the observed significant behavioural changes.PMID:38584560 | DOI:10.2174/0115748863285429240326172920 (Source: Epilepsy Curr)
Source: Epilepsy Curr - April 8, 2024 Category: Neurology Authors: Hemangi Amrutbhai Virani Hetal Kantilal Dabhi Piyushkumar Mansinh Pargi Source Type: research
Levetiracetam Induced Behavioural Changes in an Adult Female Patient: A Case Report
CONCLUSION: Consequently, the drug was discontinued, resulting in the resolution of the behavioural symptoms. This case highlights levetiracetam as the likely causative factor behind the observed significant behavioural changes.PMID:38584560 | DOI:10.2174/0115748863285429240326172920 (Source: Epilepsy Curr)
Source: Epilepsy Curr - April 8, 2024 Category: Neurology Authors: Hemangi Amrutbhai Virani Hetal Kantilal Dabhi Piyushkumar Mansinh Pargi Source Type: research
Levetiracetam Induced Behavioural Changes in an Adult Female Patient: A Case Report
CONCLUSION: Consequently, the drug was discontinued, resulting in the resolution of the behavioural symptoms. This case highlights levetiracetam as the likely causative factor behind the observed significant behavioural changes.PMID:38584560 | DOI:10.2174/0115748863285429240326172920 (Source: Epilepsy Curr)
Source: Epilepsy Curr - April 8, 2024 Category: Neurology Authors: Hemangi Amrutbhai Virani Hetal Kantilal Dabhi Piyushkumar Mansinh Pargi Source Type: research
Levetiracetam Induced Behavioural Changes in an Adult Female Patient: A Case Report
CONCLUSION: Consequently, the drug was discontinued, resulting in the resolution of the behavioural symptoms. This case highlights levetiracetam as the likely causative factor behind the observed significant behavioural changes.PMID:38584560 | DOI:10.2174/0115748863285429240326172920 (Source: Epilepsy Curr)
Source: Epilepsy Curr - April 8, 2024 Category: Neurology Authors: Hemangi Amrutbhai Virani Hetal Kantilal Dabhi Piyushkumar Mansinh Pargi Source Type: research
Levetiracetam Induced Behavioural Changes in an Adult Female Patient: A Case Report
CONCLUSION: Consequently, the drug was discontinued, resulting in the resolution of the behavioural symptoms. This case highlights levetiracetam as the likely causative factor behind the observed significant behavioural changes.PMID:38584560 | DOI:10.2174/0115748863285429240326172920 (Source: Epilepsy Curr)
Source: Epilepsy Curr - April 8, 2024 Category: Neurology Authors: Hemangi Amrutbhai Virani Hetal Kantilal Dabhi Piyushkumar Mansinh Pargi Source Type: research
An introduction to epilepsy care
Curr Probl Pediatr Adolesc Health Care. 2024 Apr 2:101591. doi: 10.1016/j.cppeds.2024.101591. Online ahead of print.NO ABSTRACTPMID:38570217 | DOI:10.1016/j.cppeds.2024.101591 (Source: Epilepsy Curr)
Source: Epilepsy Curr - April 3, 2024 Category: Neurology Authors: Whitney Fitts Shavonne L Massey Jillian L McKee Marisa S Prelack Source Type: research
An introduction to epilepsy care
Curr Probl Pediatr Adolesc Health Care. 2024 Apr 2:101591. doi: 10.1016/j.cppeds.2024.101591. Online ahead of print.NO ABSTRACTPMID:38570217 | DOI:10.1016/j.cppeds.2024.101591 (Source: Epilepsy Curr)
Source: Epilepsy Curr - April 3, 2024 Category: Neurology Authors: Whitney Fitts Shavonne L Massey Jillian L McKee Marisa S Prelack Source Type: research
An introduction to epilepsy care
Curr Probl Pediatr Adolesc Health Care. 2024 Apr 2:101591. doi: 10.1016/j.cppeds.2024.101591. Online ahead of print.NO ABSTRACTPMID:38570217 | DOI:10.1016/j.cppeds.2024.101591 (Source: Epilepsy Curr)
Source: Epilepsy Curr - April 3, 2024 Category: Neurology Authors: Whitney Fitts Shavonne L Massey Jillian L McKee Marisa S Prelack Source Type: research
